
|Articles|July 1, 2004
Multiple courses of alefacept safe for psoriasis tx
Toronto - The biologic medication alefacept (Amevive, Biogen, Inc.) may be safely administered to psoriasis patients in multiple courses as well as in conjunction with other standard therapies, according to a presentation at the 10th International Psoriasis Symposium here.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
4
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
5



















